The Centre for Community-Driven Research has become the latest patient-focused group to criticise the Pharmaceutical Benefits Advisory Committee's failure to recommend a simplified and faster reimbursement process for immunotherapies.
'Our job as advocates is to interpret what patients mean by hope, not to ignore it'
October 23, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Pilot study confirms adjunct NB-UVB needed to activate repigmentation in vitiligo
June 18, 2025 - - Australian Biotech -
Montu pushes for national standards at Productivity Commission inquiry
June 17, 2025 - - Latest News -
Canadian appointed to lead New Zealand's Pharmac
June 17, 2025 - - Latest News -
US FDA approves CSL's treatment for hereditary angioedema
June 17, 2025 - - Latest News -
Australia's system is more uniform than the US, but not uniformly better
June 17, 2025 - - Latest News -
Australian company secures FDA approval to progress development of CAR-T therapy
June 16, 2025 - - Latest News -
These systems are and always have been more similar than most realise
June 16, 2025 - - Latest News